The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

NCT07362355 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Gout and Hyperuricemia

Interventions

DRUG: SHR4640 ；Febuxostat
DRUG: SHR4640 ; Febuxostat
DRUG: SHR4640
DRUG: SHR4640
DRUG: Febuxostat

Sponsor

Jiangsu HengRui Medicine Co., Ltd.